Treatment for Depression and Anxiety

Accordingly , this kind of drug interferes with the balance of the hormone dopamine and nor epinephrine in the brain advancing the idea that the said two chemicals are very minimal during the state of depression . It is stated the deficiencies in one or more of the neurotransmitter in the brain such as nor epinephrine , dopamine , and serotonin usually produces depression and may be due to genetic predisposition or external psychosocial factors . This ultimately led to the development of psychotropic drugs which includes the like TCA , SSRI and MAOI . In 2005 however , a

group of physicians conducted a research aimed at evaluating the efficiency of SSRI therapy for anxiety or depression , most specifically in the aspect of comparing the potency between branded and generic drugs (Sheehan Et al . 2005 ,

br 403 . Of the 21 ,430 patients , 71 .2 or 15 ,256 took a generic SSRI in the likes of citalopram , fluoxetine , fluvoxamine , paroxetine while 28 .8 or 6 ,174 patients started treatment with branded SSRI such as Zoloft Lexapro , or Paxil (Ibid . Their conclusion provided evidence that there is not much of a difference whether the medications taken in by the patient is branded or generic . In addition , the initial choice of antidepressant is most likely to change due to other factors that needs to be considered , one of which may involve the efficacy of such drug as suppose to the metabolic rate of the patient taking such medication . It is therefore essential to account for clinical efficacy , tolerability adherence , as well as the possibility of other comorbid mood diss present , prior to the prescribing SSRI (Ibid

At present the most form of treatment for anxiety and depression is cognitive therapy or psychotherapy (Young Et al . 2006 br

.904 . It is most often applied as a combination of cognitive-behavioral therapy , but...